Read More Pharma Industry News Novartis announces promising long-term data on Kesimpta for relapsing multiple sclerosis In a significant revelation, Novartis Pharmaceuticals Corporation has announced the latest findings from the ALITHIOS open-label extension study.… byPallavi MadhirajuApril 18, 2024